Advertisement
The addition of the GS FLX(TM) system brings with it a ten fold increasein sequence read-length compared to other next generation platforms; readswhich approach those of Sanger-based technologies. The increased read lengthof the GS FLX(TM) system is the primary factor behind SeqWright's capabilityof offering de novo sequencing of higher organisms and the system's greatestadvantage over competitive platforms.
Advertisement
The capacity of SeqWright to provide cost effective genomic solutions forvirtually any genomics project stems from the synergy created by thecombination of the GS FLX(TM) with the company's existing SOLiD(TM) platform.The long read lengths of the GS FLX(TM) combined with the extremely highthroughput of SOLiD(TM) are a perfect complement to each other. For example,utilizing the strengths of the two systems, SeqWright can create a scaffoldsequence using the long reads of the GS FLX(TM) and subsequently combine thatscaffold with the vast amounts of sequence data from SOLiD(TM) to build up thegenomic coverage. When compared to Sanger-based methods, the decrease in costand the increase in speed of SeqWright's dual-system, next generation,approach is remarkable.
SeqWright Senior VP, David Buck, Ph.D., remarked this regardingSeqWright's recent acquisition, "The 454 platform is quite a natural additionto our next generation services division as it enables us to take on many morelarge-scale genomics projects and makes these sort of projects within reach ofmany more genomics researchers."
About SeqWright:
SeqWright Incorporated is a world-class genomic services supportorganization based in Houston, TX with more than fourteen years of experiencespecializing in providing access to state of the art Molecular Biology andGenomic services in a highly regulated GLP/CLIA environment. For additionalinformation about SeqWright and its services, please visithttp://www.seqwright.com.
SOURCE SeqWright Incorporated
